A comprehensive view of Phase 1 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

University of Wisconsin, Madison, partners with TRYP Therapeutics to study safety of intravenous and oral psilocybin to assess how drug is absorbed by the body in healthy adults; Phase 1 study not yet open for recruiting
Published: July 26, 2022 by Contify Life Science News
PMV Pharmaceuticals collaborates with Merck in Phase 1/2 clinical trials to evaluate oral small molecule oncology therapy PC14586 in combination with Merck’s injectable KEYTRUDA pembrolizumab; therapy used to treat advanced solid tumors
Published: July 19, 2022 by GlobeNewswire
AstraZeneca acquiring blood cancer drug firm TeneoTwo for US$100M, with milestone payments of up to US$805M and US$360M; deal includes injectable T-cell engager TNB-486 currently in Phase 1 clinical trial to treat B-cell non-Hodgkin lymphoma
Published: July 07, 2022 by Marketline - Deals
FDA lifts clinical hold on Phase1/2 study of Vertex Pharma's stem cell-derived VX-880 injectable therapy to treat type 1 diabetes; trial reopening for screening, enrollment, dosing at sites in US
Published: July 06, 2022 by SeeNews Pharmaceuticals
FDA approves Cybin’s New Drug Application for clinical trial evaluating oral CYB003 deuterated psilocybin analog to treat major depressive disorder; drug is first novel psilocybin analog to start clinical development, with Phase1/2a trial starting soon
Published: June 28, 2022 by Business Wire

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count